Gallicchio R, Nardelli A, Calice G, Guarini A, Guglielmi G, Storto G
F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study
Eur J Radiol (ISSN: 0720-048xlinking), 2021 Mar; 136: 109564-109564.

Fonti R, Pellegrino S, Catalano L, Pane F, Del Vecchio S, Pace L
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma
Ann Hematol (ISSN: 0939-5555linking), 2020 Jan; 99(1): 127-135.

Tornatore L, Capece D, D'Andrea D, Begalli F, Verzella D, Bennett J, Acton G, Campbell EA, Kelly J, Tarbit M, Adams N, Bannoo S, Leonardi A, Sandomenico A, Raimondo D, Ruvo M, Chambery A, Oblak M, Al-obaidi MJ, Kaczmarski RS, Gabriel I, Oakervee HE, Kaiser MF, Wechalekar A, Benjamin R, Apperley JF, Auner HW, Franzoso G
Preclinical toxicology and safety pharmacology of the first-in-class GADD45beta/MKK7 inhibitor and clinical candidate, DTP3
Toxicol Rep (ISSN: 2214-7500linking), 2019 Apr 19; 6: 369-379.

Testino G, Leone S, Fagoonee S, Pellicano R
Alcoholic liver fibrosis: detection and treatment
Hepatology (ISSN: 0026-4806linking, 1827-1669electronic), 2018 Sep 13; 109(6): 457-471.

Conson M, Cella L, Pacelli R
Risk stratification in prostate cancer treated with radiation therapy: a window of opportunity for new clinical trials
Translational Cancer Research, 2016; N/D: N/D-N/D.

Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, Pane F, Salvatore M, Del Vecchio S
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Apr; 40(4): 303-308.

Fonti R, Pace L, Cerchione C, Catalano L, Pane F, Salvatore M, Del Vecchio S
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the Prediction of Outcome of Patients with Multiple Myeloma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015 Jan 20; 40: 303-308.

Petretta M, Nappi C, Cuocolo A
Quantification of myocardial perfusion in clinical trials
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2015; 22(2): 262-265.

Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C, Capece D, D'Andrea D, Bua M, Boyle E, van Duin M, Zoppoli P, Jaxa-Chamiec A, Thotakura AK, Dyson J, Walker BA, Leonardi A, Chambery A, Driessen C, Sonneveld P, Morgan G, Palumbo A, Tramontano  A, Rahemtulla A, Ruvo M, Franzoso G
Cancer-selective targeting of the NF-kappaB survival pathway with GADD45beta/MKK7 inhibitors
Cancer Cell (ISSN: 1535-6108), 2014 Oct 13; 26(4): 495-508.

Fonti R, Larobina M, Del Vecchio S, Fabbricini R, Catalano L, Pane F, Salvatore M, Pace L
Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Dec; 53(12): 1829-1835.

Mainenti PP
Imaging features of small bowel amyloidosis at PET/CT
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2012 Oct; 37(5): 911-911.

Petretta M, Cuocolo A
Pitfalls in statistical methods
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2012 Sep; 19(4): 818-818.

Pier PM
RE: Imaging Features of Hepato-Splenic Amyloidosis at PET/CT
Korean Journal Of Radiology (ISSN: 1229-6929), 2012 May; 13(3): 368-369.

Giacco R, Della Pepa G, Luongo D, Riccardi G
Whole grain intake in relation to body weight: From epidemiological evidence to clinical trials
Nutrition (ISSN: 0939-4753, 1590-3729electronic), 2011 Dec; 21(12): 901-908.

Fonti R, Larobina M, Fabbricini R, Catalano L, Pace L, Del Vecchio S, Salvatore M
Metabolic Tumor Volume assessed by 18F-FDG-PET/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M
F-18-FDG PET/CT, Tc-99m-MIBI, and MRI in evaluation of patients with multiple myeloma
J Nucl Med (ISSN: 0161-5505, 0161-1550, 1535-5667), 2008 Feb; 49(2): 195-200.

Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M
18F-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: N/D-N/D.

Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Del Vecchio S, Pace L, Salvatore M, Rotoli B
F-18-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 2007 Oct; 92: N/D-N/D.

Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Del Vecchio S, Pace L, Salvatore M, Rotoli B
F-18-FDG-PET/CT, 99mTC-MIBI and MRI in the evaluation of patients with multiple myeloma
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 2007 Oct; 92: N/D-N/D.

Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis
Ann Hematol (ISSN: 0939-5555, 0939-5555linking), 2007 Jun; 86(6): 415-423.

Cusanno F, Cisbani E, Colilli S, Fratoni R, Garibaldi F, Giuliani F, Gricia M, Lucentini M, Magliozzi ML, Santarivenere F, Torrioli S, Cinti MN, Pani R, Pellegrini R, Simonetti G, Schillaci O, Del Vecchio S, Salvatore M, Majewski S, De Vincentis G, Scopinaro F
Results of clinical trials with SPEM
Nucl Instrum Methods Phys Res Sect A, 2007 Feb 1; 497(1): 46-50.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M
Multimodality Imaging With 18f-Fdg-Pet/Ct, 99mtc-Mibi And Mri Of Multiple Myeloma
Proceedings Of The 2nd International Conference Of The European Society For Molecular Imaging Naples Italy, 2007; N/D: 56-56.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Cammarano F, Segreto S, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the evaluation of patients with multiple myeloma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.

Cuocolo A, Acampa W, Varrone A, Salvatore M
Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.

Pace L, Salvatore M, Del Vecchio S
Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2006 Mar; 47(3): 555-555.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Cammarano F, Segreto S, Petruzziello F, Catalano L, Martinelli V, Rotoli B, Del Vecchio S, Pace L, Salvatore M
18f-Fdg-Pet/Ct, 99mtc-Mibi And Mri Inpatients With Multiple Myeloma
Multimodality Imaging With Proceedings Of The Ix Congress Of The Italian Society Of Experimental Hematology, 2006; PO164: 53-53.

Catalano L, Andretta C, Pace L, Del Vecchio S, Salvatore B, De Rosa G, Buonanno MT, Paone G, Rotoli B
Tc 99-Sesta Mibi Uptake In Nonsecretory Multiple Myeloma
Hematology (ISSN: 1024-5332), 2005 Sep; 10(4): 335-338.

Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B, Andretta C, Di Nuzzo C, Rotoli B, Salvatore M
Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2005 Sep; 49(3): 281-285.

Pace L, Del Vecchio S, Salvatore M
Technetium 99m sestamibi in multiple myeloma
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005 Jan; 234(1): 312-313.

Pace L, Del Vecchio S, Salvatore M, Walker RC, Angtuaco E, Sethi R, Fassas A, Barlogie B
Technetium 99m sestamibi in multiple myeloma [3] (multiple letters)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005; 234(1): 312-313.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.

Pace L, Salvatore M, Del Vecchio S
A new role for nuclear medicine in multiple Myeloma
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2003 Sep; 44(8): 1369-1369.

Andretta C, Catalano L, Pace L, Fonti R, Annunziata G, Rotoli B
99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients [2]
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2003 Jun; 44(6): 1081-1082.

Marino M, Rossi M, Ruvo M, Fassina G
Novel molecular targets for systemic lupus erythematosus
Curr Drug Targets (ISSN: 1389-4501), 2002 Jun; 3(3): 223-228.

Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Sica G, Annunziata G, Califano C, Rotoli B, Salvatore M
Wash-out of 99mTc-sestamibi (99mTc-MIBI) in evaluating response to chemotherapy in patients with multiple myeloma (MM)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.

Pace L, Catalano L, Del Vecchio S, Di Gennaro F, De Renzo A, Sica G, Califano C, Tedesco N, Borrelli G, Rotoli B, Salvatore M
Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Mar; 28(3): 304-312.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001; 28(2): 214-220.

Blocklet D, Schoutens A, Kentos A, Feremans W, Fonti R, Del Vecchio S, Pace L
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma [1] (multiple letters)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001; 28(9): 1430-1432.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.

Del Vecchio S, Fonti R, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.

Di Gennaro F, Catalano L, Pace L, de Renzo A, Pinto AM, del Vecchio S, Rotoli B, Salvatore M
Tc-99m sestamibi scintigraphy in multiple myeloma
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1999 Feb; 24(2): 115-116.

Catalano L, Pace L, Califano C, Pinto AM, De Renzo A, Di Gennaro F, Del Vecchio S, Fonti R, Salvatore M, Rotoli B
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1998 Nov 15; 92(10): 119-124.

Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M
Different patterns of technetium-99m sestamibi uptake in multiple myeloma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1998 Jul; 25(7): 714-720.

Iaffaioli RV, Facchini G, Tortoriello A, Scala S, Pacelli R, La Mura G, Pagliarulo C, Palmieri G, Caponigro F
Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphoma
J Exp Ther Oncol (ISSN: 1359-4117), 1996 Jul; 1(4): 226-230.

Ferrara LA, Mancini M, Marotta T, Pasanisi F, Fasano ML
Interference by sulphinpyrazone with the antihypertensive effects of oxprenolol
Eur J Clin Pharmacol Springer Verlag (ISSN: 0031-6970, 1432-1041), 1986; 29(6): 717-719.